(2026). Tumour‐informed workflow to use ctDNA as a biomarker for risk of recurrence in head and neck cancer patients post‐treatment. View.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Tumour‐informed Workflow to Use CtDNA as a Biomarker for Risk of Recurrence in Head and Neck Cancer Patients Post‐treatment."
View 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Tumour‐informed Workflow to Use CtDNA as a Biomarker for Risk of Recurrence in Head and Neck Cancer Patients Post‐treatment."
View, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.